KIF11 inhibition for glioblastoma treatment: Reason to hope or a struggle with the brain?

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Valensin, Silvia ^a   Ghiron, Chiara ^a   Lamanna, Claudia ^a   Kremer, Andreas ^a   Rossi, Marco ^a   Ferruzzi, Pietro ^a   Nievo, Marco ^a   Bakker, Annette ^a  

^a Siena Biotech SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; HYDROLASE INHIBITOR; ISPINESIB DERIVATIVE; KINESIN; KINESIN INHIBITOR; MONASTROL; PROTEIN KIFI 1; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; ISPINESIB; KIF11 PROTEIN, HUMAN; QUINAZOLINE DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CANCER CELL CULTURE; CELL CYCLE ARREST; CONTROLLED STUDY; DRUG PENETRATION; EMBRYO; GLIOBLASTOMA; HUMAN; HUMAN CELL; NEUROTOXICITY; NONHUMAN; RAT; TOXICITY TESTING; ANIMAL; ASTROCYTE; BRAIN CORTEX; BRAIN TUMOR; CELL CYCLE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MITOSIS SPINDLE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; ASTROCYTES; BENZAMIDES; BRAIN NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CEREBRAL CORTEX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; KINESIN; MITOTIC SPINDLE APPARATUS; QUINAZOLINES; RATS;

EID: 67651098631     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-196     Document Type: Article

References (26)

1. Maher EA Furnari FB Bachoo RM Rowitch DH Louis DN Cavenee WK DePinho RA Malignant glioma: Genetics and biology of a grave matter Genes & Development 2006, 15:1311-1333. 10.1101/gad.891601
2. Bent Van den MJ The role of chemotherapy in brain metastasis European Journal of Cancer 2003, 39:2114-2120. 10.1016/S0959-8049(03)00577-X 14522368
3. Hochberg FH Pruitt A Assumptions in the radiotherapy of glioblastoma Neurology 1980, 9:907-11.
4. Lombardo F Blake JF Curatolo WJ Computation of brain-blood partitioning of organic solutes via free energy calculations J Med Chem 1996, 24:4750-5. 10.1021/jm960163r
5. Weaver BAA Cleveland DW Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death Cancer Cell 2005, 8:7-12. 10.1016/j.ccr.2005.06.011 16023594
6. De Bonis S Skoufias DA Lebeau L Lopez Robin G Margolis RL Wade RH In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities Molecular Cancer Therapeutics 2004, 3:1079-1090. 15367702
7. Goodson HV Kang SJ Endow SA Molecular Phylogeny of the kinesin family of microtubule motor proteins Journal of Cell Science 1994, 107:1875-1884. 7983154
8. Vale RD Fletterick RJ The design plan of kinesin motors Annual Review of Cell and Developmental Biology 1997, 13:745-777. 10.1146/ annurev.cellbio.13.1.745
9. Hirokawa N Kinesin and dynein superfamily proteins and the mechanism of organelle transport Science 1998, 279:519-526. 10.1126/ science.279.5350.519 9438838
10. Kull FJ Motor proteins of the kinesin superfamily: Structure and mechanism Essays Biochem 2000, 35:61-73. 12471890
11. Barry M Millecamps S Julien J Garcia M New movement in neurofilament transport, turnover and disease Exp Cell Res 2007, 313:2110-20. 10.1016/ j.yexcr.2007.03.011 17451679
12. Clark DE In silico prediction of blood brain barrier permeation Drug Discov Today 2003, 8:927-933. 10.1016/S1359-6446(03)02827-7 14554156
13. Muller C Gross D sarli V Gartner M Giannis A Bernhardt G Buschauer A Inhibitors of Kinesin EG5: Antirpoliferative activity of monastrol analogues human glioblastoma cells Cancer Chemother Pharmacol 2007, 59:157-164. 10.1007/s00280-006-0254-1 16703323
14. Coleman PJ Fraley ME Inhibitors of the mitotic kinesin spindle protein Expert Opin Ther Patents 2004, 12:1659-1667. 10.1517/13543776.14.12.1659
15. Tao W South VJ Zhang Y Davide JP Farrell L Kohl NE Sepp-Lorenzino L Lobell RB Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage Cancer Cell 2005, 8:49-59. 10.1016/j.ccr.2005.06.003 16023598
16. Tao W South VJ Diehl RE Davide JP Sepp-Lorenzino L Fraley ME Arrington KL Lobell RB An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis Molecular and Cellular Biology 2007, 27:689-698. 10.1128/ MCB.01505-06
17. Brier S Lemaire D De Bonis S Forest E Kozielski Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5 Biochemestry 2004, 43:13072-13082. 10.1021/ bi049264e
18. Koller E Propp S Zhang H Zhao C Xiao X Chang M Hirsch S Shepard P Koo S Murphy C Glazer R Dean N Use of chemically modified antisense oligonucleotide library and validate Eg5 (Kinesin-like 1) as a target for antineoplastic drug development Cancer Research 2006, 66:2059-2066. 10.1158/0008-5472.CAN-05-1531 16489005
19. Abraham MH Chada S Mitchell R Hydrogen Bonding 33 Factors that Influence the Distribution of solutes between blood and brain J Pharm Sci 1994, 83:1257-1268. 10.1002/jps.2600830915 7830242
20. Crivori P Cruciani G Carrupt PA Testa B Predicting Blood-Brain barrier Permeation from Three-Dimensional Molecular Structure J Med Chem 2000, 43:2204-2216. 10.1021/jm990968+ 10841799
21. Lad L Luo L Carson JD Wood KW Hartman JJ Copeland RA Sakowicz Mechanism of inhibition of human KSP by ispinesib Biochemistry 2008, 47(11):3576-85. 10.1021/bi702061g 18290633
22. Jackson JR Auger KR Gilmartin AG Eng WK Luo L Concha N Sutton D Diamond M Giardiniere M Zhang S Belmont L Lee Y Anderson R Wood KW Sakowicz R Huang PS GlaxoSmithKline, 1Collegeville PA C207 A Resistance Mechanism for the KSP Inhibitor ispinesib Implicates Point Mutations in the Compound Binding Site Cytokinetics, South San Francisco, CA 2005 [Molecular targets and cancer theraputics AACR-NCI-E]
23. Knight SD Parrish CA Recent progress in the identification and clinical evaluation of inhibitors of the mitotic kinesin KSP Curr Topics Med Chem 2008, 8:888-904. 10.2174/156802608784911626
24. Cruciani G Crivori PA Carrupt PA Testa B Molecular Fields in Quantitative Structure-Permeation Relationships: The VolSurf approach J Mol Struct 2000, 503:17-30.
25. Fraley ME Garbaccio RM Arrington KL Hoffman WF Tasber ES Coleman PJ Buser CA Eileen S Walsh ES Hamilton K Christine Fernandes C Michael D Schaber MD Lobell RB Tao W South VJ Yan Y Kuo LC Prueksaritanont T Shu C Torrent M Heimbrook DC Kohl NE Huber HE Hartman GD Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP Bioorganic & Medicinal Chemistry Letters 2006, 16:1775-79. 10.1016/j.bmcl.2006.01.030 16439123
26. Copani A Condorelli F Caruso A Vancheri C Sala A Giuffrida SAM Canonico PL Nicoletti F Sortino MA Mitotic signaling by beta-amyloid causes neuronal death FASEB J 1999 13 2225 2234 10593870